BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 16720547)

  • 1. An overview of cytidine deaminases.
    Navaratnam N; Sarwar R
    Int J Hematol; 2006 Apr; 83(3):195-200. PubMed ID: 16720547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
    Conticello SG; Thomas CJ; Petersen-Mahrt SK; Neuberger MS
    Mol Biol Evol; 2005 Feb; 22(2):367-77. PubMed ID: 15496550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.
    Jarmuz A; Chester A; Bayliss J; Gisbourne J; Dunham I; Scott J; Navaratnam N
    Genomics; 2002 Mar; 79(3):285-96. PubMed ID: 11863358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Vif protein blocks the cytidine deaminase activity of B-cell specific AID in E. coli by a similar mechanism of action.
    Santa-Marta M; Aires da Silva F; Fonseca AM; Rato S; Goncalves J
    Mol Immunol; 2007 Jan; 44(4):583-90. PubMed ID: 16580072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.
    Eto T; Kinoshita K; Yoshikawa K; Muramatsu M; Honjo T
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12895-8. PubMed ID: 14559972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function.
    Severi F; Chicca A; Conticello SG
    Mol Biol Evol; 2011 Mar; 28(3):1125-9. PubMed ID: 21172829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis.
    Rogozin IB; Basu MK; Jordan IK; Pavlov YI; Koonin EV
    Cell Cycle; 2005 Sep; 4(9):1281-5. PubMed ID: 16082223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy.
    Izumi T; Shirakawa K; Takaori-Kondo A
    Mini Rev Med Chem; 2008 Mar; 8(3):231-8. PubMed ID: 18336343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
    Beale RC; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; Neuberger MS
    J Mol Biol; 2004 Mar; 337(3):585-96. PubMed ID: 15019779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system.
    Krause K; Marcu KB; Greeve J
    Mol Immunol; 2006 Feb; 43(4):295-307. PubMed ID: 15963568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.
    Bonvin M; Greeve J
    Curr Opin Infect Dis; 2008 Jun; 21(3):298-303. PubMed ID: 18448976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase.
    Kohli RM; Abrams SR; Gajula KS; Maul RW; Gearhart PJ; Stivers JT
    J Biol Chem; 2009 Aug; 284(34):22898-904. PubMed ID: 19561087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.
    Suspène R; Guétard D; Henry M; Sommer P; Wain-Hobson S; Vartanian JP
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8321-6. PubMed ID: 15919829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The AID/APOBEC family of nucleic acid mutators.
    Conticello SG
    Genome Biol; 2008; 9(6):229. PubMed ID: 18598372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-redundancy of cytidine deaminases in class switch recombination.
    Fugmann SD; Rush JS; Schatz DG
    Eur J Immunol; 2004 Mar; 34(3):844-849. PubMed ID: 14991614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo.
    Petit V; Guétard D; Renard M; Keriel A; Sitbon M; Wain-Hobson S; Vartanian JP
    J Mol Biol; 2009 Jan; 385(1):65-78. PubMed ID: 18983852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.
    Love RP; Xu H; Chelico L
    J Biol Chem; 2012 Aug; 287(36):30812-22. PubMed ID: 22822074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse APOBEC1 cytidine deaminase can induce somatic mutations in chromosomal DNA.
    Caval V; Jiao W; Berry N; Khalfi P; Pitré E; Thiers V; Vartanian JP; Wain-Hobson S; Suspène R
    BMC Genomics; 2019 Nov; 20(1):858. PubMed ID: 31726973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.
    Jost S; Turelli P; Mangeat B; Protzer U; Trono D
    J Virol; 2007 Oct; 81(19):10588-96. PubMed ID: 17652382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice deficient in APOBEC2 and APOBEC3.
    Mikl MC; Watt IN; Lu M; Reik W; Davies SL; Neuberger MS; Rada C
    Mol Cell Biol; 2005 Aug; 25(16):7270-7. PubMed ID: 16055735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.